We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Booster Shots for the Immune Compromised
U.S. agencies recommend a third COVID-19 vaccine for primary immunodeficiency patients and organ transplant recipients.
Cleaning and the Delta Variant
The COVID-19 variant is surging, but experts say you don’t have to change the way you clean.
Yes, You Can Donate Plasma After Vaccination
Patients need life-saving medicines made from plasma. You can donate plasma after receiving a vaccination against COVID-19.
Five Tips for Managing Mental Health
In year two of a pandemic, take care of yourself and create a healthy work environment for others, experts say.
Research Aimed at the Sickest COVID-19 Patients
Dr. William Zhang receives the American Thoracic Society/CSL Behring Research Award to study Acute Respiratory Distress Syndr…
Ready to Return to Working On-Sites
Ahead of all employees soon returning to working on-sites, CSL CEO Paul Perreault puts in time at the company’s Pennsylvania …
CSL CEO Paul Perreault on Australia
“It is personal. My headquarters are in Melbourne, I want to get back,” Perreault tells the Australian Financial Review’s BOS…
Biotech Firms Respond to IP Debate
Hundreds of CEOs sign a joint statement, saying IP “created the biotech network that responded so quickly to the COVID crisis…
A Pathway Out of the Pandemic
CSL CEO Paul Perreault talks vaccines, business confidence and innovation at a University of Melbourne event.
Officials Meet With the Rare Disease Community
The experts encouraged patients to get vaccinated but acknowledged questions about COVID-19 vaccine effectiveness for those w…
Alpha 1 Patients and COVID-19
The Alpha-1 Foundation urges U.S. patients to stay vigilant because some are at higher risk of serious complications.
3 Things to Know About Antibodies
For some, production of antibodies isn’t a sure thing, complicating the hoped-for end of the COVID-19 pandemic.
Popular search terms:
Americas
Asia Pacific
Europe
This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
